Ironwood Pharmaceuticals (IRWD) Announces Exercise of Option in Public Offering of Common Stock
Down)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that the underwriters of its previously announced public offering of Class A common stock have exercised their option to purchase an additional 787,500 shares at a public offering price of $15.09 per share. As a result, the Company will issue a total of 6,037,500 shares in the offering and will receive aggregate net proceeds, after underwriting discounts and commissions and other estimated offering expenses, of approximately $85.3 million. The offering is expected to close on February 15, 2012, subject to the satisfaction of customary closing conditions.
J.P. Morgan Securities LLC and BofA Merrill Lynch acted as lead joint bookrunning managers and Morgan Stanley & Co. LLC acted as joint bookrunning manager of the offering.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
J.P. Morgan Securities LLC and BofA Merrill Lynch acted as lead joint bookrunning managers and Morgan Stanley & Co. LLC acted as joint bookrunning manager of the offering.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, Morgan Stanley, Merrill Lynch, Bank of AmericaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
